PTK2 and neoplasm: Targeted degradation of FAK by PROTAC not only blocks the kinase activity but also inhibits its non-kinase function as a scaffold protein, showing promising inhibitory effects on tumor cell metastasis and promoting liver cancer cell differentiation and apoptosis.